You have 9 free searches left this month | for more free features.

Disease Progression

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Recruiting
  • Liver Fibroses
  • +4 more
  • Observation only
  • Ansan, Korea, Republic of
  • +25 more
Oct 10, 2021

Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma (ccRCC)
  • +2 more
  • Scottsdale, Arizona
  • +16 more
Aug 16, 2021

Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Bifidobacterium Bifidum Oral Product
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022

Endometrial Cancer, Atypical Hyperplasia Trial (Ozempic, Mirena)

Not yet recruiting
  • Endometrial Cancer
  • Atypical Hyperplasia
  • (no location specified)
Oct 3, 2023

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Recruiting
  • Sarcoma
  • Preoperative RT
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Oct 11, 2021

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

Terminated
  • Squamous Cell Carcinoma of the Head and Neck
  • San Francisco, California
  • +9 more
Dec 6, 2022

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Metastatic Melanoma Trial in Lancaster, Philadelphia (Hypofractionated Radiation Therapy (HFRT), Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Melanoma
  • Hypofractionated Radiation Therapy (HFRT)
  • +2 more
  • Lancaster, Pennsylvania
  • +1 more
Mar 30, 2022

Lung Diseases, Interstitial Trial in Tampa (Actigraph CP Insight Watch)

Not yet recruiting
  • Lung Diseases, Interstitial
  • Actigraph CP Insight Watch
  • Tampa, Florida
    University of South Florida/ Tampa General Hospital
May 10, 2023

Chronic Graft-versus-host-disease Trial in Goyang-si, Incheon, Seoul (SCM-CGH, Placebo)

Recruiting
  • Chronic Graft-versus-host-disease
  • SCM-CGH
  • Placebo
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +6 more
Sep 26, 2021

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban

Not yet recruiting
  • Patient With Anterior Myocardial Infarction
  • -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
  • (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
  • Sohag, Egypt
    Sohag University Hospital
Feb 16, 2023

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

NSCLC Trial in Goyang-si (BIBW 2992, simvastatin)

Completed
  • Non-small Cell Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

Recruiting
  • Liver and Intrahepatic Bile Duct Carcinoma
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 11, 2022

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Pancreatic Adenocarcinoma Metastatic
  • Scottsdale, Arizona
    Clinical Trials Nurse Navigator
Oct 3, 2023

Glioblastoma Multiforme Trial in United States (ERAS-801)

Recruiting
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +6 more
Nov 14, 2022

Heart Failure Trial in Cairo (myocardial function after surgery)

Recruiting
  • Heart Failure
  • myocardial function after surgery
  • Cairo, Egypt
  • +1 more
Oct 13, 2023

Melanoma Trial in Nantes, Paris, Villejuif (MaaT013, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma
  • Nantes, France
  • +2 more
Mar 28, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +5 more
  • TG4010
  • Nivolumab
  • Duarte, California
  • +3 more
Oct 11, 2021

Multiple Myeloma Trial in Canada (Bortezomib)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +6 more
Aug 28, 2020